Marta Rayo
Lunar (Scientific & Regulatory Affairs Associate Director) and Sara Sánchez Vidaurre (Scientific
& Regulatory Affairs Officer) learnt more about recent advances in biomarkers in rheumatic disorders. Marta
talked about regulatory considerations of biomarkers qualification for clinical
use.
Although
significant challenges remain, progress continues to be made in biomarker
discovery and development for rheumatic diseases.
Asphalion will keep you informed!
Search News & Events
Share
As Brexit is quickly coming closer, the CMDh has published an updated version of the Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP in December 2020.
Asphalion is excited and proud to officially welcome Javier Febrero Alija to its team as Regulatory Information Manager, expert in Data Management and RIMS.
We wish you Happy ‘Xmas, Prosperous New Year and Health for you and your loved ones.
Services
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
Memberships & PartnershipS
Quality Management System
Innovative SME
SDGs
As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
